Dr. Anita Goel, MD, PhD, is the President and Scientific Director of Nanobiosym Labs and the President and CEO of Nanobiosym Diagnostics, Inc. Nanobiosym Diagnostics, Inc. is the commercial arm of Nanobiosym that is developing next-generation diagnostic capabilities. Nanobiosym Labs focuses on fundamental research at the interface of Physics, Medicine, and Nanotechnology, and maximizing the global impact of this synergy, with a focus on both developed and emerging areas.
Dr. Goel's work at Nanobiosym has been recognized by several prestigious funding awards worth millions of dollars from the United States Department of Defense agencies including Defense Advanced Research Projects Agency (DARPA), Air Force Office of Scientific Research (AFOSR) and US Dept of Energy (DOE) and US Defense Threat Reduction Agency (DTRA). She has been an esteeemed keynote speaker at numerous symposia, international conferences, and university colloquia. Her extensive list of honors also includes the 2006 MIT Global Indus Technovator Award, an honor recognizing the contributions of top 10 leaders working at the forefront of science, technology, and entrepreneurship.
A Harvard-MIT trained physicist and physician, Dr. Anita Goel, was named in 2005 one of the "top 35 science and technology innovators under the age of 35" by MIT's Technology Review Magazine. Dr. Goel holds both a PhD in Physics from Harvard University and an MD from the Harvard-MIT Joint Division of Health Sciences and Technology (HST) and BS in Physics from Stanford University.
She is a Fellow of the World Technology Network, a Fellow-at-Large of the Santa Fe Institute, and an Associate of the Harvard Physics Department, and Adjunct Professor of BEYOND institute for Fundamental Concepts in Science. She serves on the Board of Trustees and Scientific Advisory Board of India-Nano, an organization devoted to bridging breakthrough advances in nanotechnology with the burgeoning Indian nanotech sector.
Last Thursday, April 24, nanotechnology entrepreneur Anita Goel, founder of Medford, MA-based Nanobiosym, testified on the National Nanotechnology Initiative, a hearing held by the U.S. Senate Subcommittee on Science, Technology,... Read more »